Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Responds to CMS Proposed Rule for CY 2022 PFS and Other Policy Changes (NCD 180.2)
-
Group Sign-On Letter Supporting the VITAL Act
-
Group Letter to Biden Administration Regarding Patent Eligibility Reform
-
ACMG Letter of Support for the Expanded Genetic Screening Act
-
Group Sign-on Letter to Congress Supporting the Medicare Sequester COVID Moratorium Act
-
Group Sign-on Letter to Congress Expressing Concerns about Patent Eligibility Reform Stakeholder Discussions
-
Group Sign-on Letter to CMS Urging Coverage of CPT Code 99072 in Response to the Public Health Emergency
-
ACMG Letter to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act
-
ACMG Comments to CMS about Proposed Changes to the PFS for CY 2021
-
Group Sign-on Letter to HHS Supporting Clarification of LDT Regulatory Process